Quanta BioDesign, located in Powell, OH, is a leading innovator in the development of SuperHydrophilic dPEG technology for the creation of high-quality life science reagents and assays. Their dPEG products, including building blocks and protected linkers, enable the transformation of hydrophobic peptides into hydrophilic products, simplifying peptide analysis and enhancing performance. With a focus on simplicity and precision, Quanta BioDesign's dPEG technology offers unique advantages over dispersed PEG linkers, making it a preferred choice for researchers in the field.
Quanta BioDesign's commitment to advancing bioconjugate chemistry is evident in their development of new cross-linking and labeling chemistries that incorporate dPEG technology. Their innovative approaches have opened up new possibilities in therapeutic and diagnostic development, providing researchers with powerful tools for drug discovery and bioconjugate applications. With a range of featured products, including crosslinking reagents, payload delivery reagents, and click chemistry solutions, Quanta BioDesign continues to drive advancements in the life sciences field.
Generated from the website